Skin & cosmetic

Melanotan II

MT-II

Research compoundEvidence: AnecdotalPeptideLimited human dataSerious adverse events reported

A synthetic analog of alpha-melanocyte-stimulating hormone. Primarily studied for its ability to stimulate melanin production, causing skin tanning without UV exposure.

Also known as: MT-2, Melanotan 2, melanotan

Status
Melanotan II is a research compound and not approved by the FDA for human use.
Evidence
Anecdotal. Mostly community reports; there is no controlled human data.
Half-life
~1 hour
How it's taken
Subcutaneous injection
Mechanism
Melanocortin receptor
Pathways
Melanocortin

How Melanotan II works

Binds to melanocortin receptors (MC1R) in skin cells, triggering melanin production. Also has effects on MC3R and MC4R receptors, which influence appetite and sexual function.

What research has looked at

Evidence level: Anecdotal. Mostly community reports; there is no controlled human data. These are areas studied or reported, not promised effects.

Reported side effects and risks

Sources

  1. PubMed research on melanotan II safety melanocortin · NIH · National Library of Medicine
  2. DrugBank record for melanotan II · DrugBank
  3. StatPearls / NCBI Bookshelf on melanotan II · NCBI Bookshelf

Track Melanotan II in Peptide Vault

Log every dose, set reminders on your own schedule, rotate injection sites and keep your vials organized. Peptide Vault records what you enter. It doesn't recommend compounds or doses. iPhone, on-device.

Get Peptide Vault

Related compounds

Melanotan II FAQ

What is Melanotan II?

A synthetic analog of alpha-melanocyte-stimulating hormone. Primarily studied for its ability to stimulate melanin production, causing skin tanning without UV exposure.

How does Melanotan II work?

Binds to melanocortin receptors (MC1R) in skin cells, triggering melanin production. Also has effects on MC3R and MC4R receptors, which influence appetite and sexual function.

Is Melanotan II FDA approved?

No. Melanotan II is a research compound and not approved by the FDA for human use. Evidence level: anecdotal. Mostly community reports; there is no controlled human data.

What is the half-life of Melanotan II?

Reported half-life: ~1 hour.

How is Melanotan II taken?

Subcutaneous injection.

What side effects have been reported with Melanotan II?

Reported in the sources: Nausea (very common initially); Facial flushing; Fatigue; New or changed moles (monitor closely); Potential darkening of existing moles; Not FDA-approved — significant safety concerns.

Educational summary compiled from the sources listed above. Not medical advice. Peptide Vault does not sell, source or recommend any compound. Talk to a qualified clinician before starting or changing anything.